A Phase IIb Open-label, Multi-centre, Extension Study to Explore the Long-term Safety and Efficacy of KH176 in Subjects With a Genetically Confirmed Mitochondrial DNA tRNALeu(UUR) m.3243A>G Mutation Who Have Completed the KHENERGYZE Study KH176-202.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT04604548

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:39:55.339625+00:00

Published At

2024-03-06T00:00:00+00:00

Record Updated At

2024-03-06

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Mitochondrial Diseases", "Mitochondrial DNA tRNALeu(UUR) m.3243A\u003cG Mutation", "Maternally Inherited Diabetes and Deafness (MIDD)", "Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke Like Episodes (MELAS)", "Chronic Progressive External Ophthalmoplegia (CPEO)"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2024-03-06"

protocolSection.identificationModule.nctId

"NCT04604548"

protocolSection.identificationModule.officialTitle

"A Phase IIb Open-label, Multi-centre, Extension Study to Explore the Long-term Safety and Efficacy of KH176 in Subjects With a Genetically Confirmed Mitochondrial DNA tRNALeu(UUR) m.3243A\u003eG Mutation Who Have Completed the KHENERGYZE Study KH176-202."

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Mitochondrial Diseases (protocolSection.conditionsModule.conditions)
• Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation (protocolSection.conditionsModule.conditions)
• Maternally Inherited Diabetes and Deafness (MIDD) (protocolSection.conditionsModule.conditions)
• Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke Like Episodes (MELAS) (protocolSection.conditionsModule.conditions)
• Chronic Progressive External Ophthalmoplegia (CPEO) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.